These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15314096)

  • 1. Lovastatin exacerbates atypical absence seizures with only minimal effects on brain sterols.
    Serbanescu I; Ryan MA; Shukla R; Cortez MA; Snead OC; Cunnane SC
    J Lipid Res; 2004 Nov; 45(11):2038-43. PubMed ID: 15314096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain sterols in the AY-9944 rat model of atypical absence seizures.
    Cortez MA; Cunnane SC; Snead OC
    Epilepsia; 2002 Jan; 43(1):3-8. PubMed ID: 11879380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in serum sterols of rats treated with 7-dehydrocholesterol-delta 7-reductase inhibitors: comparison to levels in humans with Smith-Lemli-Opitz syndrome.
    Wolf C; Chevy F; Pham J; Kolf-Clauw M; Citadelle D; Mulliez N; Roux C
    J Lipid Res; 1996 Jun; 37(6):1325-33. PubMed ID: 8808767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A chronic model of atypical absence seizures: studies of developmental and gender sensitivity.
    Persad V; Cortez MA; Snead OC
    Epilepsy Res; 2002 Jan; 48(1-2):111-9. PubMed ID: 11823115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABA receptor proteins within lipid rafts in the AY-9944 model of atypical absence seizures.
    Huo JZ; Cortez MA; Snead OC
    Epilepsia; 2009 Apr; 50(4):776-88. PubMed ID: 19054408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin depletion attenuates AY-9944-mediated atypical absence seizures.
    Bercovici E; Cortez MA; Wang X; Snead OC
    Epilepsia; 2006 Feb; 47(2):240-6. PubMed ID: 16499747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormonal regulation of atypical absence seizures.
    Persad V; Ting Wong CG; Cortez MA; Wang YT; Snead OC
    Ann Neurol; 2004 Mar; 55(3):353-61. PubMed ID: 14991813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refractory atypical absence seizures in rat: a two hit model.
    Serbanescu I; Cortez MA; McKerlie C; Snead OC
    Epilepsy Res; 2004 Nov; 62(1):53-63. PubMed ID: 15519132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal exposure to AY-9944 increases typical spike and wave discharges in WAG/Rij and Wistar rats.
    Perescis MFJ; van Luijtelaar G; van Rijn CM
    Epilepsy Res; 2019 Nov; 157():106184. PubMed ID: 31539657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selective GABAB antagonist CGP-35348 blocks spike-wave bursts in the cholesterol synthesis rat absence epilepsy model.
    Smith KA; Fisher RS
    Brain Res; 1996 Aug; 729(2):147-50. PubMed ID: 8876982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholesterol biosynthesis from lanosterol: regulation and purification of rat hepatic sterol 14-reductase.
    Kim CK; Jeon KI; Lim DM; Johng TN; Trzaskos JM; Gaylor JL; Paik YK
    Biochim Biophys Acta; 1995 Oct; 1259(1):39-48. PubMed ID: 7492613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epileptic activity during early postnatal life in the AY-9944 model of atypical absence epilepsy.
    Jung S; Jeong Y; Jeon D
    Cell Calcium; 2015 May; 57(5-6):376-84. PubMed ID: 25890840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cholesterol in the regulation of growth plate chondrogenesis and longitudinal bone growth.
    Wu S; De Luca F
    J Biol Chem; 2004 Feb; 279(6):4642-7. PubMed ID: 14612457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol prevents the teratogenic action of AY 9944: importance of the timing of cholesterol supplementation to rats.
    Barbu V; Roux C; Lambert D; Dupuis R; Gardette J; Maziere JC; Maziere C; Elefant E; Polonovski J
    J Nutr; 1988 Jun; 118(6):774-9. PubMed ID: 2453625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daily rhythms of seizure activity and behavior in a model of atypical absence epilepsy.
    Stewart LS; Bercovici E; Shukla R; Serbanescu I; Persad V; Mistry N; Cortez MA; Snead OC
    Epilepsy Behav; 2006 Dec; 9(4):564-72. PubMed ID: 17030024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the last two enzymatic reactions in cholesterol biosynthesis in rats: effects of BM 15.766, cholesterol, cholic acid, lovastatin, and their combinations.
    Honda A; Shefer S; Salen G; Xu G; Batta AK; Tint GS; Honda M; Chen TC; Holick MF
    Hepatology; 1996 Aug; 24(2):435-9. PubMed ID: 8690416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a nonisotopic technique for studies of in vivo cholesterol metabolism in mini-pigs using inhibition of 7-dehydrocholesterol reductase by AY 9944.
    Kaiser W; Stocker K
    Res Exp Med (Berl); 1978 Dec; 174(1):79-108. PubMed ID: 83665
    [No Abstract]   [Full Text] [Related]  

  • 18. Lovastatin treatment inhibits sterol synthesis and induces HMG-CoA reductase activity in mononuclear leukocytes of normal subjects.
    Stone BG; Evans CD; Prigge WF; Duane WC; Gebhard RL
    J Lipid Res; 1989 Dec; 30(12):1943-52. PubMed ID: 2621421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of AY 9944 and chlorpromazine on Concanavalin A-induced stimulation of human lymphocytes.
    Barbu V; Mazière JC; Maindrault F; Mazière C; Rampini C; Roux C; Polonovski J
    Biochem Pharmacol; 1987 Feb; 36(3):353-6. PubMed ID: 2434099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of lifibrol (K12.148) on the cholesterol metabolism of cultured cells: evidence for sterol independent stimulation of the LDL receptor pathway.
    Scharnagl H; Schliack M; Löser R; Nauck M; Gierens H; Jeck N; Wieland H; Gross W; März W
    Atherosclerosis; 2000 Nov; 153(1):69-80. PubMed ID: 11058701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.